Black, Dennis M, Austin R Thompson, Richard Eastell, and Mary L Bouxsein. 2024. “Bone Mineral Density As a Surrogate Endpoint for Fracture Risk Reduction in Clinical Trials of Osteoporosis Therapies: An Update on SABRE.”. The Lancet. Diabetes & Endocrinology 12 (6): 371-73.
